dihydrochandonium iodide has been researched along with androstane-3,17-diol in 1 studies
| Studies (dihydrochandonium iodide) | Trials (dihydrochandonium iodide) | Recent Studies (post-2010) (dihydrochandonium iodide) | Studies (androstane-3,17-diol) | Trials (androstane-3,17-diol) | Recent Studies (post-2010) (androstane-3,17-diol) |
|---|---|---|---|---|---|
| 7 | 1 | 0 | 1,124 | 64 | 70 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biró, K; Kárpáti, E | 1 |
1 other study(ies) available for dihydrochandonium iodide and androstane-3,17-diol
| Article | Year |
|---|---|
The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
Topics: Androstane-3,17-diol; Androstanes; Animals; Cats; Dogs; Drug Interactions; Female; Hemodynamics; Histamine Release; Male; Mice; Mice, Inbred Strains; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pipecuronium; Piperazines; Rats; Synaptic Transmission | 1981 |